دورية أكاديمية

Two novel CD40LG gene mutations causing X-linked hyper IgM syndrome in Vietnamese patients.

التفاصيل البيبلوغرافية
العنوان: Two novel CD40LG gene mutations causing X-linked hyper IgM syndrome in Vietnamese patients.
المؤلفون: Lien NTK; Institute of Genome Research, Vietnam Academy of Science and Technology, 18 - Hoang Quoc Viet str., Caugiay, Hanoi, Vietnam., Van Anh NT; Allergy, Immunology and Rheumatology Department, Vietnam National Hospital Pediatrics, 18/879 La Thanh str., Dongda, Hanoi, Vietnam., Chi LQ; Allergy, Immunology and Rheumatology Department, Vietnam National Hospital Pediatrics, 18/879 La Thanh str., Dongda, Hanoi, Vietnam., Le NNQ; Allergy, Immunology and Rheumatology Department, Vietnam National Hospital Pediatrics, 18/879 La Thanh str., Dongda, Hanoi, Vietnam., Huyen TT; Allergy, Immunology and Rheumatology Department, Vietnam National Hospital Pediatrics, 18/879 La Thanh str., Dongda, Hanoi, Vietnam., Mai NTP; Human Genetics Department, Vietnam National Hospital Pediatrics, 18/879 La Thanh str., Dongda, Hanoi, Vietnam., Van Tung N; Institute of Genome Research, Vietnam Academy of Science and Technology, 18 - Hoang Quoc Viet str., Caugiay, Hanoi, Vietnam.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, 18 - Hoang Quoc Viet str., Cau Giay, Ha Noi, Vietnam., Hoang NH; Institute of Genome Research, Vietnam Academy of Science and Technology, 18 - Hoang Quoc Viet str., Caugiay, Hanoi, Vietnam. nhhoang@igr.ac.vn.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology, 18 - Hoang Quoc Viet str., Cau Giay, Ha Noi, Vietnam. nhhoang@igr.ac.vn.
المصدر: Clinical and experimental medicine [Clin Exp Med] 2023 Feb; Vol. 23 (1), pp. 157-161. Date of Electronic Publication: 2021 Nov 29.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Milano, Italy: Springer-Verlag Italia, c2001-
مواضيع طبية MeSH: Hyper-IgM Immunodeficiency Syndrome, Type 1*/diagnosis , Hyper-IgM Immunodeficiency Syndrome, Type 1*/genetics , Hyper-IgM Immunodeficiency Syndrome, Type 1*/therapy, Child ; Humans ; Southeast Asian People ; Vietnam ; CD40 Ligand/genetics ; Mutation ; Immunoglobulin M
مستخلص: The X-linked hyper IgM syndrome is a primary immunodeficiency disorder (PID) due to mutations in the CD40LG gene. Hyper IgM syndrome is characterized by the absence or decreased levels of IgG and IgA and normal or elevated IgM levels in serum. Affected patients become susceptible to infections such as pneumonia, diarrhea, and skin ulcer types. Hematopoietic stem cell transplantation is the only treatment currently available and ideally performed before the age of 10 years. Early, accurate diagnosis will contribute to the effective treatment for patients with hyper IgM. The patients from different Vietnamese families who have been diagnosed with hyper IgM at The Allergy, Immunology and Rheumatology Department, Vietnam National Hospital Pediatrics, were performed a genetic analysis using whole exome sequencing. The mutations were confirmed by the Sanger sequencing method in patients and their families. The influence of the mutations was predicted with the in silico analysis tools: PROVEAN, SIFT, PolyPhen-2, and MutationTaster. In this study, two novel mutations (p.Thr254fs and p.Leu138Phe) in the CD40LG gene were found in Vietnamese patients with X-linked hyper IgM syndrome. Our results contribute to the general understanding of the etiology of the disease and can help diagnose the different forms of PID.
(© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
References: Davies EG, Thrasher AJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol. 2010;149:167–80. (PMID: 10.1111/j.1365-2141.2010.08077.x201807972855828)
Franca TT, Leite LFB, Maximo TA, et al. A novel de novo mutation in the CD40 ligand gene in a patient with a mild X-linked hyper-IgM phenotype initially diagnosed as CVID: new aspects of old diseases. Front Pediatr. 2018;6:130. (PMID: 10.3389/fped.2018.00130297807955945832)
de la Morena MT. Clinical phenotypes of hyper-IgM syndromes. J Allergy Clin Immunol Pract. 2016;4:1023–36. (PMID: 10.1016/j.jaip.2016.09.01327836054)
Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84. (PMID: 10.1097/01.md.0000100046.06009.b014663287)
Leven EA, Maffucci P, Ochs H, et al. Hyper IgM syndrome: a report from the USIDNET registry. J Clin Immunol. 2016;36:490–501. (PMID: 10.1007/s10875-016-0291-4271893785039943)
Allen RC, Armitage RJ, Conley ME, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259:990–3. (PMID: 10.1126/science.76798017679801)
van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 2000;67:2–17. (PMID: 10.1002/jlb.67.1.210647992)
Rawat A, Mathew B, Pandiarajan V, et al. Clinical and molecular features of X-linked hyper IgM syndrome – an experience from North India. Clin Immunol. 2019;195:59–66. (PMID: 10.1016/j.clim.2018.07.013)
Dunn CP, de la Morena MT. X-linked hyper-IgM syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. University of Washington, Seattle; 2020. pp. 1993–2021.
Ferrua F, Galimberti S, Courteille V, et al. Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study. J Allergy Clin Immunol. 2019;143(6):2238–53. (PMID: 10.1016/j.jaci.2018.12.101030660643)
Aghamohammadi A, Parvaneh N, Rezaei N, et al. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol. 2009;29:769–76. (PMID: 10.1007/s10875-009-9315-719575287)
Aloui C, Sut C, Prigent A, et al. Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions? Sci Rep. 2014;4:7239. (PMID: 10.1038/srep07239254300875384113)
Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745–7. (PMID: 10.1093/bioinformatics/btv195258519494528627)
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protocols. 2009;4(7):1073–82. (PMID: 10.1038/nprot.2009.8619561590)
Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9. (PMID: 10.1038/nmeth0410-248203545122855889)
Schwarz JM, Rödelsperger C, Schuelke M, et al. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–6. (PMID: 10.1038/nmeth0810-57520676075)
Pace CN, Fu H, Fryar KL, et al. Contribution of hydrogen bonds to protein stability. Protein Sci. 2014;23:652–61. (PMID: 10.1002/pro.2449245913014005716)
Lee WI, Torgerson TR, Schumacher MJ, et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105:1881–90. (PMID: 10.1182/blood-2003-12-442015358621)
Alizadeh Z, Mazinani M, Houshmand M, et al. Genetic analysis of patients with two different types of hyper IgM syndrome. Immunol Invest. 2018;47(7):745–53. (PMID: 10.1080/08820139.2018.149305230081731)
Li L, Ji J, Han M, et al. A novel CD40L mutation associated with X-linked hyper IgM syndrome in a Chinese family. Immunol Invest. 2020;49(3):307–16. (PMID: 10.1080/08820139.2019.163839731401902)
Wang LL, Zhou W, Zhao W, et al. Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome. J Immunol Res. 2014. https://doi.org/10.1155/2014/683160 . (PMID: 10.1155/2014/683160253865644352485)
فهرسة مساهمة: Keywords: CD40LG gene; Hyper IgM; Mutation; Primary immunodeficiency; Vietnamese patients; Whole exome sequencing
المشرفين على المادة: 147205-72-9 (CD40 Ligand)
0 (Immunoglobulin M)
تواريخ الأحداث: Date Created: 20211129 Date Completed: 20230224 Latest Revision: 20230224
رمز التحديث: 20231215
DOI: 10.1007/s10238-021-00774-0
PMID: 34842998
قاعدة البيانات: MEDLINE
الوصف
تدمد:1591-9528
DOI:10.1007/s10238-021-00774-0